A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)

Katsunori Shinozaki, Takeshi Yamada, Junichiro Nasu, Toshihiko Matsumoto, Yasuhiro Yuasa, Takeshi Shiraishi, Hiroaki Nagano, Ichiro Moriyama, Toshiyoshi Fujiwara, Masashi Miguchi, Ryosuke Yoshida, Kimiyasu Nozaka, Hiroaki Tanioka, Takeshi Nagasaka, Yasuro Kurisu, Michiya Kobayashi, Kenji Tsuchihashi, Michio Inukai, Takashi Kikuchi, Tomohiro Nishina

研究成果: Contribution to journalArticle査読

2 被引用数 (Scopus)

フィンガープリント 「A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences